Financial Ratios Nomura Research Institute, Ltd.
Equities
4307
JP3762800005
IT Services & Consulting
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,053.00 JPY | -3.96% |
|
-4.00% | -32.69% |
| 08/02 | Japan's Takaichi set for major lower house victory | RE |
| 08/02 | INSTANT VIEW-Japan's Takaichi set for major lower house victory | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.71 | 8.87 | 8.41 | 8.44 | 9.04 | |||||
Return on Total Capital | 11.62 | 11.75 | 11.11 | 11.08 | 11.86 | |||||
Return On Equity % | 16.95 | 21.25 | 20.54 | 19.91 | 22.45 | |||||
Return on Common Equity | 17.55 | 21.33 | 20.67 | 19.95 | 22.5 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 33.76 | 35.33 | 34.65 | 35.44 | 36 | |||||
SG&A Margin | 17.87 | 18.56 | 19.01 | 19.33 | 18.84 | |||||
EBITDA Margin % | 22.5 | 23.64 | 22.35 | 22.69 | 23.89 | |||||
EBITA Margin % | 15.06 | 16.78 | 15.83 | 16.15 | 17.5 | |||||
EBIT Margin % | 15.06 | 16.78 | 15.83 | 16.15 | 17.5 | |||||
Income From Continuing Operations Margin % | 9.55 | 11.74 | 11.05 | 10.88 | 12.34 | |||||
Net Income Margin % | 9.61 | 11.68 | 11.02 | 10.81 | 12.26 | |||||
Net Avail. For Common Margin % | 9.61 | 11.68 | 11.02 | 10.81 | 12.26 | |||||
Normalized Net Income Margin | 8.38 | 10.3 | 9.61 | 9.82 | 10.87 | |||||
Levered Free Cash Flow Margin | 10.59 | 7.42 | 7.74 | 10.76 | 7.92 | |||||
Unlevered Free Cash Flow Margin | 10.71 | 7.56 | 8.17 | 11.28 | 8.39 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.93 | 0.85 | 0.85 | 0.84 | 0.83 | |||||
Fixed Assets Turnover | 7.16 | 7.34 | 9.2 | 10.3 | 11.79 | |||||
Receivables Turnover (Average Receivables) | 4.62 | 5.05 | 5.18 | 5.39 | 5.1 | |||||
Inventory Turnover (Average Inventory) | - | - | - | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.85 | 1.12 | 1.76 | 1.89 | 1.75 | |||||
Quick Ratio | 1.49 | 0.84 | 1.32 | 1.47 | 1.36 | |||||
Operating Cash Flow to Current Liabilities | 0.49 | 0.33 | 0.6 | 0.66 | 0.54 | |||||
Days Sales Outstanding (Average Receivables) | 78.97 | 72.21 | 70.47 | 67.94 | 71.63 | |||||
Days Outstanding Inventory (Average Inventory) | - | - | - | - | - | |||||
Average Days Payable Outstanding | - | 42.06 | 44.17 | 41.84 | 41.45 | |||||
Cash Conversion Cycle (Average Days) | - | - | - | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 49.7 | 73.12 | 59.08 | 74.08 | 61.88 | |||||
Total Debt / Total Capital | 33.2 | 42.24 | 37.14 | 42.55 | 38.23 | |||||
LT Debt/Equity | 38.83 | 35.4 | 51.73 | 68.06 | 50.85 | |||||
Long-Term Debt / Total Capital | 25.94 | 20.45 | 32.52 | 39.1 | 31.41 | |||||
Total Liabilities / Total Assets | 49.25 | 56.63 | 51.99 | 56.32 | 52.83 | |||||
EBIT / Interest Expense | 82.49 | 74.28 | 22.8 | 19.51 | 23.54 | |||||
EBITDA / Interest Expense | 123.2 | 104.63 | 32.18 | 27.41 | 32.15 | |||||
(EBITDA - Capex) / Interest Expense | 115.6 | 99.69 | 29.67 | 26.19 | 30.98 | |||||
Total Debt / EBITDA | 1.34 | 1.73 | 1.54 | 1.79 | 1.48 | |||||
Net Debt / EBITDA | 0.1 | 0.93 | 0.7 | 0.75 | 0.56 | |||||
Total Debt / (EBITDA - Capex) | 1.43 | 1.82 | 1.67 | 1.87 | 1.54 | |||||
Net Debt / (EBITDA - Capex) | 0.11 | 0.98 | 0.76 | 0.78 | 0.58 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.06 | 11.14 | 13.17 | 6.41 | 3.84 | |||||
Gross Profit, 1 Yr. Growth % | 2.73 | 16.29 | 10.99 | 8.83 | 5.47 | |||||
EBITDA, 1 Yr. Growth % | 9 | 16.79 | 6.97 | 8.03 | 9.36 | |||||
EBITA, 1 Yr. Growth % | -0.33 | 23.83 | 6.74 | 8.54 | 12.52 | |||||
EBIT, 1 Yr. Growth % | -0.33 | 23.83 | 6.74 | 8.54 | 12.52 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -25.11 | 36.54 | 6.55 | 4.79 | 17.74 | |||||
Net Income, 1 Yr. Growth % | -23.69 | 35.14 | 6.81 | 4.37 | 17.73 | |||||
Normalized Net Income, 1 Yr. Growth % | -11.18 | 36.61 | 5.59 | 8.75 | 14.94 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -19.2 | 36.56 | 7.1 | 6.18 | 19.53 | |||||
Accounts Receivable, 1 Yr. Growth % | -19.34 | 27.61 | -3.01 | 7.81 | 11.58 | |||||
Inventory, 1 Yr. Growth % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 42.37 | -15.33 | -3.22 | -6.62 | -12.21 | |||||
Total Assets, 1 Yr. Growth % | 23.14 | 20.28 | 6.15 | 10.09 | 0.62 | |||||
Tangible Book Value, 1 Yr. Growth % | 29.18 | -46.73 | 25.74 | -17.02 | 23.55 | |||||
Common Equity, 1 Yr. Growth % | 21.5 | 2.68 | 17.58 | 0.13 | 8.64 | |||||
Cash From Operations, 1 Yr. Growth % | -17.7 | 16.01 | 21.16 | 19.66 | -8.49 | |||||
Capital Expenditures, 1 Yr. Growth % | 53.45 | -10.61 | 76.74 | -37.95 | -11.01 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -20.82 | -22.1 | 17.96 | 47.96 | -23.55 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -20.31 | -21.47 | 22.25 | 46.83 | -22.78 | |||||
Dividend Per Share, 1 Yr. Growth % | 12.5 | 11.11 | 12.5 | 17.78 | 18.87 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 4.78 | 7.54 | 12.15 | 9.74 | 5.12 | |||||
Gross Profit, 2 Yr. CAGR % | 6.2 | 9.3 | 13.61 | 9.91 | 7.14 | |||||
EBITDA, 2 Yr. CAGR % | 10.25 | 12.83 | 11.77 | 7.5 | 8.7 | |||||
EBITA, 2 Yr. CAGR % | 7.72 | 11.09 | 14.97 | 7.64 | 10.51 | |||||
EBIT, 2 Yr. CAGR % | 7.72 | 11.09 | 14.97 | 7.64 | 10.51 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 1.01 | 1.12 | 20.62 | 5.67 | 11.08 | |||||
Net Income, 2 Yr. CAGR % | 1.88 | 1.55 | 20.14 | 5.58 | 10.85 | |||||
Normalized Net Income, 2 Yr. CAGR % | 1.61 | 10.16 | 20.1 | 7.16 | 11.8 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 10.68 | 5.04 | 20.94 | 6.64 | 12.65 | |||||
Accounts Receivable, 2 Yr. CAGR % | -10.8 | 1.45 | 11.25 | 2.26 | 9.68 | |||||
Inventory, 2 Yr. CAGR % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 17.52 | 9.79 | -9.48 | -4.93 | -9.45 | |||||
Total Assets, 2 Yr. CAGR % | 3.56 | 21.7 | 12.99 | 8.1 | 5.25 | |||||
Tangible Book Value, 2 Yr. CAGR % | -13.2 | -17.04 | -18.16 | 2.15 | 1.26 | |||||
Common Equity, 2 Yr. CAGR % | -10.43 | 11.7 | 9.88 | 8.5 | 4.3 | |||||
Cash From Operations, 2 Yr. CAGR % | 22.53 | -2.29 | 18.55 | 20.41 | 4.64 | |||||
Capital Expenditures, 2 Yr. CAGR % | 17.53 | 17.12 | 25.69 | 4.72 | -25.69 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 28.31 | -21.46 | -4.14 | 32.11 | 6.36 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 28.5 | -20.89 | -2.02 | 33.98 | 6.48 | |||||
Dividend Per Share, 2 Yr. CAGR % | 9.54 | 11.8 | 11.8 | 15.11 | 18.32 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.29 | 6.86 | 9.38 | 10.2 | 7.73 | |||||
Gross Profit, 3 Yr. CAGR % | 5.19 | 9.46 | 9.86 | 12 | 8.41 | |||||
EBITDA, 3 Yr. CAGR % | 8.45 | 12.39 | 10.84 | 10.51 | 8.12 | |||||
EBITA, 3 Yr. CAGR % | 8.37 | 12.84 | 9.62 | 12.78 | 9.24 | |||||
EBIT, 3 Yr. CAGR % | 8.37 | 12.84 | 9.62 | 12.78 | 9.24 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -2.18 | 11.68 | 2.9 | 15.09 | 9.55 | |||||
Net Income, 3 Yr. CAGR % | -1.4 | 11.94 | 3.27 | 14.64 | 9.48 | |||||
Normalized Net Income, 3 Yr. CAGR % | 4.56 | 12.14 | 8.61 | 16.19 | 9.69 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 5.13 | 18.71 | 5.72 | 15.8 | 10.77 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.8 | 0.51 | -0.06 | 10.09 | 5.27 | |||||
Inventory, 3 Yr. CAGR % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.63 | 5.35 | 5.27 | -8.53 | -7.42 | |||||
Total Assets, 3 Yr. CAGR % | 0.2 | 8.86 | 16.28 | 12.02 | 5.55 | |||||
Tangible Book Value, 3 Yr. CAGR % | -8.76 | -26.24 | -4.71 | -17.78 | 8.84 | |||||
Common Equity, 3 Yr. CAGR % | -7.72 | -6.26 | 13.62 | 6.53 | 8.55 | |||||
Cash From Operations, 3 Yr. CAGR % | 4.8 | 20.31 | 4.97 | 18.92 | 9.88 | |||||
Capital Expenditures, 3 Yr. CAGR % | -23.32 | 7.28 | 34.34 | -0.66 | -0.81 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 18.75 | 8.65 | -10.06 | 10.78 | 10.09 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 18.89 | 9.05 | -8.54 | 12.13 | 11.5 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.52 | 10.06 | 12.04 | 13.76 | 16.35 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.48 | 7.58 | 7.98 | 8 | 7.66 | |||||
Gross Profit, 5 Yr. CAGR % | 6.73 | 8.49 | 8.48 | 9.64 | 8.76 | |||||
EBITDA, 5 Yr. CAGR % | 6.38 | 10.7 | 9.76 | 10.4 | 9.98 | |||||
EBITA, 5 Yr. CAGR % | 7.3 | 11.9 | 10.96 | 10.73 | 9.98 | |||||
EBIT, 5 Yr. CAGR % | 7.3 | 11.9 | 10.96 | 10.73 | 9.98 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 4.21 | 10.31 | 6.37 | 9.24 | 6.1 | |||||
Net Income, 5 Yr. CAGR % | 4.39 | 9.66 | 6.71 | 9.35 | 6.24 | |||||
Normalized Net Income, 5 Yr. CAGR % | 3.95 | 10.15 | 10.52 | 10.12 | 9.88 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.11 | 14.75 | 11.19 | 13.72 | 8.44 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.43 | 6.85 | 2.59 | 1.2 | 3.73 | |||||
Inventory, 5 Yr. CAGR % | - | - | - | - | - | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.67 | 3.69 | 1.55 | 1.11 | -0.89 | |||||
Total Assets, 5 Yr. CAGR % | 1.1 | 4.66 | 5.13 | 8.55 | 11.73 | |||||
Tangible Book Value, 5 Yr. CAGR % | -7.02 | -17.48 | -12.64 | -15.98 | -2.37 | |||||
Common Equity, 5 Yr. CAGR % | -4.34 | -4.87 | -1.05 | -0.61 | 9.8 | |||||
Cash From Operations, 5 Yr. CAGR % | 0.76 | 9.92 | 10.1 | 20.35 | 4.84 | |||||
Capital Expenditures, 5 Yr. CAGR % | -16.83 | -12.79 | -6.56 | 6.25 | 6.01 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.97 | 13.99 | 9 | 17.48 | -3.82 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 6.15 | 14.3 | 10.04 | 18.41 | -2.8 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.23 | 9.46 | 11.03 | 12.05 | 14.51 |
- Stock Market
- Equities
- 4307 Stock
- Financials Nomura Research Institute, Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















